Companies Backed by Third Rock Ventures
6 companies in Third Rock Ventures's investment portfolio.
Back to Third Rock Ventures profileInvestment Thesis
“Creates and builds breakthrough biopharmaceutical companies by combining cutting-edge science with experienced drug development teams.”
Portfolio Companies (2)
Editas Medicine
Editas Medicine, Inc., (formerly Gengine, Inc.), is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology.
Foundation Medicine
Foundation Medicine, Inc. is an American company based in Boston, Massachusetts, which develops, manufactures, and sells genomic profiling assays based on next-generation sequencing technology for solid tumors, hematologic malignancies, and sarcomas.
Other Investments (4)
Portfolio Analysis
Third Rock Ventures has built a portfolio of 6 companies across 1 sector, including Biotech.
The portfolio reflects investments across the IPO stage, showing Third Rock Ventures's approach to supporting companies at a focused stage of development.
Frequently Asked Questions
How many companies has Third Rock Ventures invested in?
Third Rock Ventures has invested in 6+ companies across 1 different sectors.
What sectors does Third Rock Ventures invest in?
Third Rock Ventures's portfolio spans Biotech. This diversification reflects the firm's broad investment thesis and sector expertise.
What stages does Third Rock Ventures invest at?
Third Rock Ventures invests across the IPO stage. Their portfolio includes companies at various points in their growth journey.